<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Severe aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> (SAA) causes permanent stem cell damage from which patients do not recover after treatment with antilymphocyte globulin (ALG) </plain></SENT>
<SENT sid="1" pm="."><plain>To produce peripheral blood values compatible with life, the few remaining stem and precursor cells are put under stress </plain></SENT>
<SENT sid="2" pm="."><plain>We defined a 'stress factor' (SF) for various haematopoietic lines as the ratio of the corresponding peripheral blood (PB) value to the total colony number in short-term bone marrow cultures from 86 patients with different outcomes </plain></SENT>
<SENT sid="3" pm="."><plain>Both values are expressed as percentage of <z:mpath ids='MPATH_458'>normal</z:mpath>, hence SF averages 1 in <z:mpath ids='MPATH_458'>normal</z:mpath> steady-state haematopoiesis </plain></SENT>
<SENT sid="4" pm="."><plain>SF was elevated in <z:hpo ids='HP_0000001'>all</z:hpo> patients, from 2-to 40-fold, with wide variations in different patient groups and striking differences between haematopoietic lineages </plain></SENT>
<SENT sid="5" pm="."><plain>In long-term disease-free survivors after ALG (group 1) the mean total colony count was 19% of <z:mpath ids='MPATH_458'>normal</z:mpath>, with a significantly higher proportion of erythroid burst-forming units compared to <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>They had <z:hpo ids='HP_0010972'>ineffective erythropoiesis</z:hpo> with <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> (Hb) values below, and reticulocyte counts above <z:mpath ids='MPATH_458'>normal</z:mpath>; platelet counts were 67% of <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, monocyte counts were in the high <z:mpath ids='MPATH_458'>normal</z:mpath> range, resulting in a high SF (18.7 +/- 1.9) for monocytes </plain></SENT>
<SENT sid="8" pm="."><plain>In patients who developed <z:e sem="disease" ids="C0024790" disease_type="Disease or Syndrome" abbrv="PNH">paroxysmal nocturnal haemoglobinuria</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) after ALG (group 2), <z:hpo ids='HP_0010972'>ineffective erythropoiesis</z:hpo>, reflecting haemolysis, was more pronounced and they had striking relative <z:mp ids='MP_0000220'>monocytosis</z:mp>, resulting in a significantly higher SF for monocytes (33.7 +/- 5.7) compared with group 1 (p &lt; 0.0001) </plain></SENT>
<SENT sid="9" pm="."><plain>High monocyte counts most likely reflect the relative resistance of nucleated cells to complement, compared with red cells and platelets </plain></SENT>
<SENT sid="10" pm="."><plain>Patients who developed <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) or <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) after ALG, with or without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> (group 3), had the highest SF for monocytes (39 +/- 10) </plain></SENT>
<SENT sid="11" pm="."><plain>They also had neutrophil counts in the upper range, or above <z:mpath ids='MPATH_458'>normal</z:mpath>, resulting in a high SF for neutrophils: 32 +/- 19 </plain></SENT>
<SENT sid="12" pm="."><plain>In patients with persisting or relapsing-remitting <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> without a clinically detectable clonal disorder (group 4), <z:hpo ids='HP_0000001'>all</z:hpo> values were strikingly similar to those of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> group </plain></SENT>
<SENT sid="13" pm="."><plain>In patients who achieved <z:mpath ids='MPATH_458'>normal</z:mpath> PB values after uncomplicated bone marrow transplantation (group 5), the SF averaged 3, but they also had <z:hpo ids='HP_0010972'>ineffective erythropoiesis</z:hpo> and mild relative <z:mp ids='MP_0000220'>monocytosis</z:mp>, a possible sign of occult <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>We conclude that <z:hpo ids='HP_0000001'>all</z:hpo> patients after treatment of SAA have <z:hpo ids='HP_0010972'>ineffective erythropoiesis</z:hpo> and relative <z:mp ids='MP_0000220'>monocytosis</z:mp>, and that these abnormalities probably reflect <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>We suggest that the resulting high SF for the leukocyte - particularly the monocyte line - predisposes to the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="16" pm="."><plain>We discuss how these results may provide some of the missing pieces in the puzzle of SAA/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> </plain></SENT>
</text></document>